Navigation Links
Amgen's Fourth Quarter 2008 Adjusted Earnings Per Share Increased 6 Percent to $1.06; Full Year 2008 Adjusted Earnings Per Share Increased 6 Percent to $4.55
Date:1/26/2009

,097 Other non-current liabilities 1,765 934 Stockholders' equity 20,386 17,869 ------ ------ Total liabilities and stockholders' equity $36,443 $34,639 ======= ======= Shares outstanding 1,047 1,087 Amgen Inc. Reconciliation of "Adjusted" Earnings Per Share Guidance to GAAP Earnings Per Share Guidance for the Year Ending December 31, 2009 (Unaudited) 2009 ---- "Adjusted" earnings per share guidance $4.55 - $4.75 Known adjustments to arrive at GAAP earnings: Amortization of acquired intangible assets, product technology rights (a) (0.17) Incremental non-cash interest expense (b) (0.14) - (0.16) Stock option expense (c) (0.06) - (0.08) Restructuring costs (d) (0.03) - (0.06) Amortization of acquired intangible assets, R&D technology rights (e) (0.04) ----- ----- GAAP earnings per share guidance $4.04 - $4.31 ===== ===== (a) To exclude the ongoing, non-cash amortization of acquired product technology rights, primarily ENBREL, related to the Immunex acquisition. (b) To exclude the estimated impact of the incremental non-cash interest expense related to our outstanding convertible debt resulting fr
'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Beckman Coulter Announces Fourth Quarter 2008 Earnings to be Released on Monday, February 9, 2009, After Market Closes
2. Amgen Announces Webcast of 2008 Fourth Quarter and Full Year Financial Results
3. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
4. Cepheid Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
5. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
6. BioMed Realty Trust Declares Fourth Quarter 2008 Common Stock and Preferred Stock Dividends
7. Martek Announces Fourth Quarter and FY 2008 Financial Results
8. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
9. Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
10. Hill-Rom Reports Fourth Quarter Revenue Growth of 14.1 Percent to $424 Million and Adjusted Earnings Per Fully Diluted Share From Continuing Operations of $0.58, an Increase of 52.6 Percent From the Prior Year
11. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 2015 Sanofi, a global ... second quarter of 2015. CEO Olivier Brandicourt ... performance in different businesses. Watch video ... Topics covered in the interview ... - Performance drivers - Diabetes ...
(Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: ... progressing its ground-breaking technology platforms to Phase 1 clinical ... Company delivers the best value for shareholders. ... the Company currently had an extensive program of activities ... academic partnerships and initiatives, and he was working with ...
(Date:7/29/2015)... Ala., July 29, 2015  HealthSouth ... nation,s largest providers of post-acute healthcare services, offering ... its results of operations for the second quarter ... quarter was characterized by strong volume growth in ... Adjusted EBITDA," said Jay Grinney, President and Chief ...
(Date:7/29/2015)... , July 29, 2015 ... has announced the addition of the "Global ... their offering. The Global Biosimilars Market, ... of the rapidly growing biosimilars market. With the ... striving to minimize costs, biosimilars are being viewed ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15HealthSouth Reports Results for Second Quarter 2015 16HealthSouth Reports Results for Second Quarter 2015 17HealthSouth Reports Results for Second Quarter 2015 18HealthSouth Reports Results for Second Quarter 2015 19HealthSouth Reports Results for Second Quarter 2015 20HealthSouth Reports Results for Second Quarter 2015 21HealthSouth Reports Results for Second Quarter 2015 22HealthSouth Reports Results for Second Quarter 2015 23HealthSouth Reports Results for Second Quarter 2015 24HealthSouth Reports Results for Second Quarter 2015 25HealthSouth Reports Results for Second Quarter 2015 26HealthSouth Reports Results for Second Quarter 2015 27
... Calif., July 21 Abingdon Life Sciences,announces the ... The,offices, located at 5963 La Place Court, Suite ... to Palomar Airport. Abingdon Life Sciences,Inc. is a ... on providing drug and device companies with,superior services ...
... 11:00 a.m. ET; 8:00 a.m. PT, VANCOUVER and ... MGI; OTC: MGIFF), a clinical-stage developer of drugs for,infectious ... Monday,July 21, 2008 at 11:00 a.m. ET (8:00 a.m. ... and fiscal year ended April 30, 2008 and,provide an ...
... BioEnergy International, LLC,(BioEnergy), a privately-held, biotech-based developer ... announces the,acquisition of certain assets of OmniGene ... current employees. OBI, currently based in Cambridge,MA, ... technology,and metabolic pathway engineering expertise to develop ...
Cached Biology Technology:Abingdon Life Sciences, Inc. Announces Opening of Office in Carlsbad, Ca. 2BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 2BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc. 3
(Date:7/8/2015)... , N.J. and NEW YORK , July ... Guidepoint today announced BD & Guidepoint ... companies with free access to Guidepoint,s expert network services. ... that are developing cutting-edge technologies to improve healthcare delivery ... Guidepoint research manager, each start-up entrepreneur will be able ...
(Date:7/7/2015)... DUBLIN , June 30, 2015 ... ) has announced the addition of the ... their offering. To this date, fingerprint ... biometric technology and fingerprint sensors are well developed. ... capacitive sensing technology. The domain of ...
(Date:7/2/2015)... 25, 2015 Research ... of the "Natural Language Processing Market by ... OCR, Pattern & Image Recognition) - Worldwide Forecast ... The key vendors occupying the market are ... Microsoft Corporation, NetBase Solutions, SAS Institute Inc., Verint ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
... for the first time that genetic mutations in the ... in which muscle fibers do not function properly, resulting ... as well as skeletal muscles, and titin is responsible ... research was done by Danielle Buck, a doctoral candidate ...
... grass that has spread extensively in disturbed areas throughout ... fire hazard and inhibited reforestation efforts. The weed originally ... to the conditions in Panama and produces excessive amounts ... efforts. A new study published in the open access ...
... of a deadly pathogen,s family tree may have ended centuries ... lineage with links to the modern world. An international ... most devastating pandemicsthe plague of Justinian and the Black Death, ... in Europewere caused by distinct strains of the same pathogen. ...
Cached Biology News:UA researchers find culprit behind skeletal muscle disease 2UA researchers find culprit behind skeletal muscle disease 3Effective control of invasive weeds can help attempts at reforestation in Panama 2Research uncovers historical rise, fall and re-emergence of plague strains 2Research uncovers historical rise, fall and re-emergence of plague strains 3
Polaroid black & white positive, 3 x 4 inch pack film, ISO 3000/ 36 ASA DIN (20 expsures). For use in the Polaroid Direct Copy Camera (PHC34)....
Request Info...
SHEEP ANTI ECHIS OCCELATUS (VENOM)...
... ExcelGel DNA Analysis Kit, 1. ... and high resolution DNA typing. *Semi-dry ... and clean-up. *Precast, plastic-backed gels and ... convenience and detection sensitivity. Category: ...
Biology Products: